Breathe.me

Company Overview

Snapshot

Founded in November 2015 by David Groberman, Tal Slonim, and Rahav Cohen, Breathe.me operates with 1–10 employees. The company has secured funding across one disclosed round from two investors. In June 2016, Breathe.me received funding from Sanara Ventures and Israel Innovation Authority.

Business overview

Breathe.me develops a solution for predicting and preventing respiratory attacks, offering lung-function monitoring and self-management for individuals with asthma, COPD, and other respiratory conditions. The company's core technology involves an entirely mechanical device that attaches to a smartphone, paired with a corresponding app. This device functions like a whistle, generating an acoustic tone recorded by the app, which then uses a proprietary algorithm to analyze the recording and extract spirometric values such as peak flow (PEF) and FEV1. The Breathe.me app also includes a disease-management diary for tracking measurements, symptoms, and medication usage. The solution is designed for integration into various clinical platforms, providing personalized, actionable insights to patients. Breathe.me operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Digital Healthcare, with applications in patient remote monitoring.

Company Intelligence Q&A

What is Breathe.me's primary focus?

Breathe.me focuses on developing a monitoring and management solution for individuals suffering from asthma, COPD, and other respiratory conditions, aiming to predict and prevent respiratory attacks.

When was Breathe.me founded?

Breathe.me was founded in November 2015.

Who are the founders of Breathe.me?

The co-founders of Breathe.me are David Groberman, Tal Slonim, and Rahav Cohen.

What is the core technology behind Breathe.me's solution?

Breathe.me's technology includes a mechanical device that attaches to a smartphone, which records an acoustic tone generated by the device. A proprietary algorithm then analyzes this recording to extract spirometric values like peak flow (PEF) and FEV1.

What was a key funding event for Breathe.me?

In June 2016, Breathe.me received funding from Sanara Ventures and Israel Innovation Authority.